Pharmaceutical

Juan Solis Lives A Life In The Shadows, His Health Destroyed By Valley Fever

Feb 21, 2017
Casey Christie / The Bakersfield Californian

When Juan Solis shuffles out of his dark bedroom, he’s careful not to get too close to the windows.

He makes sure he only walks his dogs at night.

If he must go out during the day, he lathers on sunscreen, makes sure his legs and arms are covered, even during the peak of summer in Bakersfield’s blistering heat. And he never forgets his sunhat.

Andrew Nixon / Capital Public Radio

A new bill that would allow Californians to opt-out of mail order pharmaceutical programs advanced Friday in the Assembly Appropriations Committee. AB 2418 would also allow patients and pharmacists to synchronize the pickup of multiple medications. 

The bill is a response to cost-savings efforts by many health insurance providers that have limited options for how patients receive their prescription drugs.

Jon Roth is the CEO of the California Pharmacists Association:

Last year, America’s pharmaceutical companies invested nearly $50 billion in research for new drugs, to treat diseases from hepatitis to depression. On this edition of The Moral Is, commentator Kaye Bonner Cummings says that despite those massive investments, new research is calling into question our reliance, or perhaps our over reliance, on prescription medication.

The views expressed on The Moral Is are those of the author and do not necessarily represent the views of Valley Public Radio.